An association between increased concentrations of cerebrospinal fluid dopamine sulfate and higher negative symptom scores in patients with schizophrenia and schizoaffective disorder.
Risby
E D
ED
Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, GA 30322.
Jewart
R D
RD
Lewine
R R
RR
Risch
S C
SC
Stipetic
M
M
McDaniel
J S
JS
Caudle
J
J
D002908:Chronic Disease; D004298:Dopamine / Q000031:analogs & derivatives* / Q000134:cerebrospinal fluid / Q000502:physiology; D006719:Homovanillic Acid / Q000134:cerebrospinal fluid; D006801:Humans; D011569:Psychiatric Status Rating Scales; D011618:Psychotic Disorders / Q000134:cerebrospinal fluid* / Q000523:psychology; D012016:Reference Values; D012559:Schizophrenia / Q000134:cerebrospinal fluid*; D012565:Schizophrenic Psychology
C022807:dopamine 4-O-sulfate; D004298:Dopamine; D006719:Homovanillic Acid